Ignaseclant

N/A

Report date: 2026/02/04 13:46:08
NME

Base Information

Drug NameIgnaseclant
Drug Alias NameBromophenoxyazole propanoic acidNMD-670NMDP-01NMDP-02NMD670
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChloride channel protein 1 inhibitors
TargetsChloride channel protein 1
Therapy Area/IndicationsCharcot-Marie-Tooth DiseaseMuscular Atrophy, SpinalMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNMD Pharma AS
China Registration ClassN/A

Develop Information

Active CompaniesNMD Pharma AS
Inactive CompaniesN/A
Active IndicationsCharcot-Marie-Tooth DiseaseMuscular Atrophy, SpinalMyasthenia Gravis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank